BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 17650425)

  • 21. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase.
    Han S; Sidell N; Roman J
    Cancer Lett; 2005 Feb; 219(1):71-81. PubMed ID: 15694666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
    Roberts PJ; Der CJ
    Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression: involvement of p38 mitogen-activated protein kinase.
    Weng MS; Ho YS; Lin JK
    Biochem Pharmacol; 2005 Jun; 69(12):1815-27. PubMed ID: 15869744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
    Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of transfected pIRES-p21(waf1)-p27(kip1) gene on the duplication of centrosomes and the proliferation of breast cancer cell line MCF-7].
    Jiang DD; Li FN; Liu XP
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(46):3295-8. PubMed ID: 20193371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells.
    Ravi RK; Thiagalingam A; Weber E; McMahon M; Nelkin BD; Mabry M
    Am J Respir Cell Mol Biol; 1999 Apr; 20(4):543-9. PubMed ID: 10100985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A-Raf and Raf-1 work together to influence transient ERK phosphorylation and Gl/S cell cycle progression.
    Mercer K; Giblett S; Oakden A; Brown J; Marais R; Pritchard C
    Oncogene; 2005 Aug; 24(33):5207-17. PubMed ID: 15856007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
    Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
    Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibitory effect of WT1 gene isoform transfection on proliferation of leukemia cell line NB4].
    Shen HL; Chen ZX; Wang W; Cen JN; Hu SY; Zhao Y
    Ai Zheng; 2006 Feb; 25(2):163-9. PubMed ID: 16480579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
    Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
    Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
    J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
    Lee M
    Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study on the regulatory mechanisms of mitogen-activated protein kinase phosphatase-1 in hypoxia inducible factor-1 trans-activation].
    Qiao TD; Liu CJ; Shi YQ; DU YL; Han S; Fan DM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):555-9. PubMed ID: 15949338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PKC isoenzymes differentially modulate the effect of thrombin on MAPK-dependent RPE proliferation.
    Palma-Nicolas JP; López E; López-Colomé AM
    Biosci Rep; 2008 Dec; 28(6):307-17. PubMed ID: 18636965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of Ras/Raf-1/ERK actions in the magnolol-induced upregulation of p21 and cell-cycle arrest in colon cancer cells.
    Hsu YF; Lee TS; Lin SY; Hsu SP; Juan SH; Hsu YH; Zhong WB; Lee WS
    Mol Carcinog; 2007 Apr; 46(4):275-83. PubMed ID: 17295239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
    Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
    J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
    Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
    Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.